Diamonds and Dogs
June 23, 2014
Diamond: Agile Therapeutics (AGRX)
Agile Therapeutics started off the week with a boom of more than 50% by 1 o'clock. The stock soared to a yearly high of $12.55 and volume reached 1.4 million, about 5 times higher than its average. Agile Therapeutics, a women's health specialty company, announced the issuance of a new patent for the company's Skinfusion delivery device used in the contraceptive patch Twirla. Twirla is currently in Phase III development and is an important factor in the company's growth. The stock had its IPO on May 23 2014 at approximately $5.50 and has since doubled. Analysts still see a bright future for the company, as price targets are set at $17 and $18. Not too many stocks receive this kind of appraisal so soon after an IPO.
Dog: ParkerVision, Inc. (PRKR)
The dog of the day is ParkerVision, Inc., a developer of radio frequency technologies and products used in semiconductor circuits for wireless communication products. The stock price fell 60% on the day after the company lost a court decision in a lawsuit regarding accusations that Qualcomm (QCOM) infringed patents related to the wireless frequency-conversion technology. ParkerVision originally won the patent decision, but the ruling was overturned. Now, the company seems to be sinking lower and lower because the court case is burning much of the cash originally used for R&D or operating expenses. The company solely relies on its cash, as they have not made any revenue in years. ParkerVision's future looks pretty dim.